Grant: Project Grant

Myasthenia Gravis (MG) is a muscle weakness disorder that can become fatal if it affects the vital muscles needed for breathing and swallowing. Detecting MG in its early stage and segregating it from other forms of similar disorders has been a challenge in providing effective treatment. In the proposed research, in collaboration with Toronto General Hospital and Sunnybrook Health Sciences Centre, we will analyse eye movement signals around the ocular region to detect ocular MG (OMG) which is a precursor for more severe forms of MG. Advanced signal processing engineering methods will be developed in capturing clues to OMG and quantify them for automatic screening purposes. The proposed methodology will then be incorporated in a mobile portable device that can be deployed as an early stage MG screening device.